Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3669-3674

  Bethune, C R ^a   Geyer, R J ^a   Spence, A M ^a   Ho, R J Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOMAL LOMUSTINE; LOMUSTINE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; DRUG TRANSPORT; FEMALE; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BRAIN NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH INHIBITORS; LIPOSOMES; LOMUSTINE; RATS; RATS, INBRED F344;

EID: 0035328529     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats
2. Designing therapeutically optimized liposomal anticancer delivery systems: Lessons from conventional liposomes
3. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes
4. Encapsulation of vincristine in liposomes reduces its toxicity and improves its antitumor efficacy
5. Cell-specific drug transfer from liposomes bearing monoclonal antibodies
6. Neurotoxicity after intracarotid nitrosourea administration: Hemodynamic changes studied by double-tracer autoradiography
7. 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and other nitrosoureas in cancer treatment: A review
8. Randomized comparisons of radiation and nitrosoureas for the treatment of malignant glioma after surgery
9. Scanning electron microscopy of cloned astrocytic lines derived from ethylnitrosourea-induced rat glioma
10. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques
11. Combined cyclotron fast-neutron and BCNU therapy in a rat brain-tumor model
12. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice
13. Liposomal blockade of the reticuloendothelial system: Improved tumor imaging with small unilamellar vesicles
14. The effect of particle size and drug release properties on pharmacokinetics of encapsulated drug in rats
15. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs
16. Increased delivery of gallium-67 to tumors using serum-stable liposomes
17. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies
18. Mechanism of uptake of nitrosourea by L5178Y lymphoblasts in vitro
19. Transport of molecules across tumor vasculature
20. Induction of capillary growth in vitro
21. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
22. Liposomes as in vivo carriers of Adriamycin: Reduced cardiac uptake and preserved antitumor activity in mice
23. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times
24. Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SCI 15 murine mammary tumor
25. Pharmacodynamics in cancer therapy
26. New directions in blood-brain barrier research. Studies with isolated human brain capillaries
27. Blood-to-brain transfer of various oxicams: Effects of plasma binding on their brain delivery
28. Cellular uptake and transport of methylprednisolone at the blood-brain barrier